SBIO Holdings Information

SBIO is an equity ETF with a total of 105 individual holdings. The top holdings are Merus stock at 3.60%, Rhythm Pharmaceuticals at 3.58%, Cytokinetics at 3.43%, Avidity Biosciences at 3.29%, and Axsome Therapeutics at 3.14%.

Total Holdings

105

Top 10 Percentage

30.33%

Asset Class

Equity

ETF Category

Health

Assets

90.84M

PE Ratio

n/a

Sector Allocation

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	MRUS	Merus N.V.	3.60%	35,296
2	RYTM	Rhythm Pharmaceuticals, Inc.	3.58%	33,000
3	CYTK	Cytokinetics, Incorporated	3.43%	56,619
4	RNA	Avidity Biosciences, Inc.	3.29%	70,573
5	AXSM	Axsome Therapeutics, Inc.	3.14%	24,437
6	MTSR	Metsera, Inc.	2.82%	49,943
7	NUVL	Nuvalent, Inc.	2.77%	30,886
8	KRYS	Krystal Biotech, Inc.	2.60%	13,367
9	ALKS	Alkermes plc	2.59%	77,832
10	PCVX	Vaxcyte, Inc.	2.51%	60,964
11	PTCT	PTC Therapeutics, Inc.	2.48%	36,873
12	ARWR	Arrowhead Pharmaceuticals, Inc.	2.48%	65,204
13	ACLX	Arcellx, Inc.	2.24%	25,188
14	CRNX	Crinetics Pharmaceuticals, Inc.	2.14%	47,415
15	PTGX	Protagonist Therapeutics, Inc.	2.03%	29,203
16	ZLAB	Zai Lab Limited	1.97%	52,616
17	MIRM	Mirum Pharmaceuticals, Inc.	1.90%	24,023
18	AKRO	Akero Therapeutics, Inc.	1.89%	37,356
19	ACAD	ACADIA Pharmaceuticals Inc.	1.85%	80,496
20	NAMS	NewAmsterdam Pharma Company N.V.	1.76%	55,261
21	VKTX	Viking Therapeutics, Inc.	1.63%	54,834
22	CGON	CG Oncology, Inc.	1.61%	37,514
23	XENE	Xenon Pharmaceuticals Inc.	1.58%	37,300
24	APLS	Apellis Pharmaceuticals, Inc.	1.57%	62,815
25	TARS	Tarsus Pharmaceuticals, Inc.	1.33%	21,452

Showing 25 of 105 holdings

Subscribe to see the full list

Activate Now

As of Oct 1, 2025